RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Post-FDAAA Changes in Drug Safety: Where Are We Today?

Post-FDAAA Changes in Drug Safety: Where Are We Today?

Posted 01 May 2009 | By

Beginning in 2004, a perfect storm of highly publicized drug withdrawals for safety reasons, allegations of drug companies withholding safety information, and growing public mistrust in the ability of the Food and Drug Administration (FDA) to protect the public health led to intense focus on drug safety that culminated in significant regulatory reform via new legislation.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.